Amryt Pharma Share Discussion Threads

[greendragon777] 31/10/2017 23:50

Thanks for the link Paps. Bitcoin has gone insane since the recent fork and it may run another bit too before possibly a serious pullback. That said, who knows where it's gonna end up.....it's all unprecedented territory. Bitcoin will be capped at 21m coins so it has a finite supply out there!

I don't think it will collapse entirely but a 50% or 60% drop wouldn't be out of the ordinary! 😲

[papillon] 31/10/2017 23:16

greendragon. O/T on Bitcoin.

"Pigs get fat, but the hogs are going to get slaughtered"

[greendragon777] 31/10/2017 18:34

I agree Paps, he's in the wrong company if he's looking for a running commentary. I think it's heads down now until AP101's interims.

At this stage I can't see the share price going anywhere until at least the new year where hopefully some new investors will start picking up interest ahead of the interim results!

Snoozie time again! 😁

[papillon] 31/10/2017 17:32

Bronxville
Posts: 5
Off Topic
Opinion: No Opinion
Price: 19.50
RE: National EB awareness week Today 07:27 A report by a firm that monitors activity on Twitter (TWTR) has found that many users of its service are not particularly active. Even worse, about 44 percent of all people signed up have never sent a single tweet. It turns out, most posting is done by few people.

Bronxville
Posts: 5
Off Topic
Opinion: No Opinion
Price: 19.375
Management are doing a fine job! Today 10:06 Down she goes where she stops nobody knows..

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

I don't know if Bronxville reads this advfn bb, greendragon, but he doesn't sound that bright.

He mentions that only a few people "tweet" on Twitter, but that's not important. What is important is the number of people who read AMYT's "tweets". Whether they respond to AMYT's "tweets" on Twitter is unimportant. Of course I don't go on Twitter!

Bronxville then posts, sarcastically, "Management are doing a fine job!" We know that management are involved in the trials for AP101 and we also know that we will only get the first, interim, update next year. The trials are being conducted scientifically so shareholders will not be getting a running commentary as they progress, Bronxville!!

We know management are overseeing an earlier stage drug, AP102 and they are trying to maximise Lojuxta sales. They might also have other irons in the fire, but we wont know about them until a deal has been concluded if they involve negotiations with another company. Bronxville is upset because the share price is gradually drifting down and he's powerless to stop it. Hard cheese, buddy! That's the lot of small shareholders. If you want a running commentary on what the company is doing you've picked on the wrong company to invest in. There are many penny share fantasy stocks listed on AIM which do provide a running commentary, however, like MTV & CTAG, they often disappear from view!

PS. Jacksonpollack could be proved correct in that the AMYT share price will continue to gradually drift down until we get good news and that good news might not come until Q2 2018, at the earliest. Of course we could get good news at any time before then, but don't count on it!

[greendragon777] 31/10/2017 15:29

That must be someone offloading a few shares for some Halloween spending money! Mwuahahaha 😁

[papillon] 30/10/2017 16:49

Only ONE trade all day! A sell for a pathetic 500 shares @ 19.25p! LOL. LOL.

[bigwavedave] 27/10/2017 13:49

TW is bonkers. I'm sure there is a clinical term but bonkers will do for now.

[bigwavedave] 27/10/2017 13:48

re bonxville: of course they are aware of it. They have been promoting it on Twitter and elsewhere, no doubt.

[papillon] 27/10/2017 12:45

I see that TW's ShareProphets site (via it's tipping arm, HotStockRockets) is tipping OPTI yet again. AMYT hasn't been tipped by the site since it's recent placing angered TW. The continuing tipping of OPTI doesn't appear to have any overall effect on the OPTI share price

PS. For the record I don't subscribe to ShareProphets, or HotStockRockets. Basically I only have one share, AMYT and I probably know as much about the company as them.

[papillon] 27/10/2017 11:16

Seen today on the lse AMYT bb.

Bronxville
Posts: 3
Off Topic
Opinion: No Opinion
Price: 19.50
National EB awareness week Today 10:24 Is this company even aware of this
Debra International have a campaign to raise money
Is management asleep at the wheel

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

Is AMYT aware that that this is "National EB awareness week"? Well I didn't know!! Whether AMYT knows I have no idea. Do you know, Bronxville?

"Is management asleep at the wheel"? No idea! Perhaps you could tell us, Bronxville?

[solomon] 26/10/2017 16:17

Paps - Always good to hear 'credit where credit is due' comments. The internet is not always that polite!

[bigwavedave] 26/10/2017 13:39

KTZ Communications hereby cordially invite you to meet Joe Wiley, CEO, and Rory Nealon, CFO & COO, of Amryt Pharma (AIM: AMYT, ESM: AYP), the rare and orphan diseases specialist, on Wednesday, 8 November 2017.
The presentation, followed by a Q&A session, will take place at 12.30pm at the offices of KTZ Communications, No.1 Cornhill, London, EC3V 3ND.
Amryt key facts:
• Strategy is to acquire, develop and commercialise medicines to treat patients with rare and orphan diseases.
• There are c7,000 identified rare diseases, but less than 10% have approved treatments.
• Existing, revenue-generating product, Lojuxta – used to treat the rare genetic cholesterol disorder, HoFH; total est. market size €100m (Europe & MENA); H1 17 sales €5.75m.
• Lead candidate, AP101 – potential treatment for the devastating skin disorder, Epidermolysis Bullosa; currently in Phase III clinical trials, interim data expected in H1 18; total est. market size €1.3bn+.
• Earlier stage asset, AP102 – potential treatment for Acromegaly and Cushing’s Disease; expected to complete pre-clinical development by end of 2017; total est. market size€900m+ (€500m+ Acromegaly, €400m+ Cushing’s Disease).
• An extremely experienced management team with >100 years of experience in healthcare and the pharmaceutical industry.
• Board chaired by Shire Pharmaceuticals̵7; founder, CEO and Chairman, Harry Stratford OBE.

[papillon] 25/10/2017 16:30

LOL., bazworth. If only I had £35k of spare cash. I would spend it on AMYT shares. I could instruct my broker from aboard my super yacht! LOL. As it is I doubt if I could buy 35 quids worth at the moment! LOL.

180,000 buy @ full ask of 19.50p. Pushed up the share price

Big sell earlier in the day. 133,406 @ below bid price (18.75p). Reporting delayed by 2 hours (OK trade).

Good volume today. Could signify the bottom?

The recent placing was oversubscribed. Could it be that the 180k buy was done by someone (an II?) who never got what they asked for in the placing? Could there be anymore such buys coming up?

[bazworth] 25/10/2017 15:59

papillon, was that you buying another 180,000? I’m impressed.....!!!!

Cheers!!

[greendragon777] 25/10/2017 14:45

If the share price hasn't gone up significantly by H2 of next year then I'll need a few of those blood pressure tablets myself! Haha

[jacksonpollack] 25/10/2017 13:48

Pap. How is having an opinion shooting my mouth off? You hope the share price will be many multiples of what it is now. That's your opinion. I'm saying I don't think that will happen this year or even into Q2 of next year. That's my opinion. Keep taking the tablets, lol.

[jacksonpollack] 25/10/2017 08:58

Oh dear. You need to get your blood pressure checked papilion. We aren't going to see eye to eye on this. Anyway nothing much happening in Amryt Pharma plc's (formerly Fastnet Equity, formerly Fastnet Oil & Gas plc, formerly Sterling Green Group plc, formerly Hamilton Partners plc). You don't need charts to see that the share price is falling and why. AIM is a news driven platform. There won't be any major announcements till mid 2018 imho. So the share price will bounce around the 15p-25p mark till then. Good money to be made if you can catch the occasional pump then dump right, though.

[bazworth] 24/10/2017 23:48

Noted

Thanks

[bazworth] 24/10/2017 22:56

At this stage, I really don’t think charts are of any relevance to AMYT. We need sound results from the Phase 3 trials as well as good news re Lojuxta volumes. Other good news may arise. Best to sit on your hands & be patient!! Or, sell....!

[papillon] 24/10/2017 21:11

This AMYT log chart is a classic case of wishful thinking on my part! I'm clutching at straws! LOL. It just goes to show that drawing parallel trend lines can be extremely subjective. Make of it what you will. However it, along with my previous chart, led me to have a small top up today.


free stock charts from uk.advfn.com